CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today announced that it was recognized by the Wall Street Journal as one of the top 50 private venture-backed companies in the United States. This is the second time that Acceleron was named to the list.
